Clinical Trial Update: Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the effects of spironolactone on matrix metalloproteinases in heart failure has completed. The study was sponsored by Tottori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Aldactone (spironolactone)

Snippet

Sponsor: Tottori University Hospital | Conditions: Chronic Stable Heart Failure | Phase 4 | Status: COMPLETED